Impact of Pre-Operative Ureteroscopy on Bladder Recurrence Following Nephroureterectomy for UTUC

Chris Ho-Ming Wong, Ivan Ching‐Ho Ko, David Leung, Kang Liu, Hongda Zhao, Mario Álvarez‐Maestro, Maria del Pilar Laguna Pes, Jean de la Rosette, Jeremy Yuen‐Chun TeohCancers 2024 · DOI

TL;DR

This study reveals that performing ureteroscopy (URS) before radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) significantly increases the risk of bladder cancer recurrence. The findings suggest a need for careful consideration of URS in the diagnostic pathway to optimize patient outcomes.

What Problem Does This Paper Address?

Upper tract urothelial carcinoma (UTUC) is a rare but aggressive cancer. Radical nephroureterectomy (RNU) is the standard treatment, but a significant concern after this surgery is the recurrence of cancer within the bladder (intravesical recurrence or IVR). Diagnostic ureteroscopy (URS) is often used to visualize and biopsy suspicious lesions in the upper urinary tract before RNU. However, there's an ongoing debate about whether performing URS itself might inadvertently spread cancer cells to the bladder, thereby increasing the risk of IVR. Previous studies have yielded conflicting results, often due to limitations like small sample sizes or single-center data. This paper aims to clarify this association by analyzing data from a large, international, multi-center registry.

Methods

The researchers utilized data from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry, a prospective, multicenter database. They included 269 patients diagnosed with non-metastatic UTUC who underwent RNU and had sufficient follow-up data. Patients were divided into two groups: those who had RNU upfront and those who underwent diagnostic URS before RNU. The primary outcome measured was intravesical recurrence-free survival (IVRS), assessed using Kaplan-Meier analysis and multivariate Cox regression. Statistical analyses were performed to identify factors associated with IVRS, with a p-value of less than 0.05 considered statistically significant.

Datasets

The study used data from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry. This is a prospective, multicenter, international database that includes data from 29 participating centers across 101 countries. The dataset comprised 269 patients with UTUC who underwent RNU.

Key Insights and Ideas

  • URS as a potential "seeding" mechanism: The study provides strong evidence that the diagnostic procedure of URS, rather than just the underlying UTUC, might contribute to bladder recurrence. This challenges the notion of URS as a purely benign diagnostic step.
  • The risk is independent of auxiliary procedures: Interestingly, common adjuncts to URS, such as ureteric access sheath use, flexible ureteroscopy, ureteric biopsy, and retrograde contrast studies, did not independently influence the risk of bladder recurrence. This suggests the risk is primarily linked to the URS procedure itself.
  • Need for careful clinical decision-making: The findings highlight a critical trade-off. While URS can provide diagnostic certainty, it comes with a quantifiable increased risk of a problematic complication (bladder recurrence). This necessitates a more nuanced approach to deciding when URS is truly essential.

Key Results

  • A total of 269 patients were analyzed, with 137 (50.9%) in the upfront RNU group and 132 (49.1%) in the pre-RNU URS group.
  • The URS group showed an inferior 24-month intravesical recurrence-free survival (IVRS) compared to the upfront RNU group.
  • The hazard ratio for recurrence in the URS group was 1.705 (95% CI = 1.082–2.688; p = 0.020).
  • Multivariate analysis confirmed pre-operative ureteroscopy as the sole statistically significant predictor of increased intravesical bladder recurrence (p = 0.019).
  • At 24 months, IVRS rates were 64% for the upfront RNU group and 52% for the ureteroscopy group.
  • Factors like ureteric access sheath usage, flexible ureteroscopy, ureteric biopsy, retrograde contrast studies, and the duration of URS did not significantly affect IVRS.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective nature: While the registry is prospective, the analysis of the data was retrospective.
  • Lack of standardization: The diagnostic URS procedures were not standardized across the numerous participating centers, which could introduce variability.
  • Unobserved confounders: Despite robust analysis, the retrospective nature means unobserved confounders might still influence the results.
  • Limited data on certain aspects: The study noted limitations in data regarding the adoption of intravesical chemotherapy post-RNU and specific operative details of RNU.

Future work suggested includes:

  • Prospective studies: The authors emphasize the need for future prospective studies, ideally with multi-arm designs, to further investigate the nuances of URS and its auxiliary procedures.
  • Investigating mechanisms: More research is needed to fully understand the mechanisms by which URS might lead to bladder recurrence.
  • Role of pre-operative intravesical chemotherapy: The role of post-URS intravesical chemotherapy needs further study.

Summary updated

Abstract

(1) Introduction: Diagnostic ureteroscopy (URS) is an important component in the workup of upper tract urothelial carcinoma (UTUC). Whether URS was associated with increased recurrence in the bladder was not fully concluded. The current study aimed to evaluate the implication of URS on the incidences of intravesical recurrence following radical nephroureterectomy (RNU) in non-metastatic UTUC patients without prior history of bladder cancer via multi-institutional data. (2) Patients and Methods: Data were obtained from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry, a prospective, multicentre database. Patients with non-metastatic UTUC treated with RNU were divided into two groups: those undergoing upfront RNU and those having diagnostic URS prior to RNU. Intravesical recurrence-free survival (IVRS) was the primary endpoint, evaluated through Kaplan-Meier analysis and multivariate Cox regression. Cases with adequate follow-up data were included. (3) Results: The analysis included 269 patients. Of these, 137 (50.9%) received upfront RNU and 132 (49.1%) received pre-RNU URS. The URS group exhibited an inferior 24-month IVRS compared to the upfront RNU group (HR = 1.705, 95% CI = 1.082-2.688; <i>p</i> = 0.020). Multivariate analysis confirmed URS as the only significant predictor of IVR (<i>p</i> = 0.019). Ureteric access sheath usage, flexible ureteroscopy, ureteric biopsy, retrograde contrast studies, and the duration of URS did not significantly affect IVRS. (4) Conclusions: Diagnostic URS prior to RNU was found to be associated with an increased risk of IVR in patients with UTUC. The risk was not significantly influenced by auxiliary procedures during URS. Physicians were advised to meticulously evaluate the necessity of diagnostic URS.
BibTeX
@inproceedings{wong2024impact,
  author = {Chris Ho-Ming Wong and Ivan Ching‐Ho Ko and David Leung and Kang Liu and Hongda Zhao and Mario Álvarez‐Maestro and Maria del Pilar Laguna Pes and Jean de la Rosette and Jeremy Yuen‐Chun Teoh},
  title = {{Impact of Pre-Operative Ureteroscopy on Bladder Recurrence Following Nephroureterectomy for UTUC}},
  booktitle = {Cancers},
  year = {2024},
  doi = {10.3390/cancers16152683},
}
Figure